Johnson & Johnson Management

Management criteria checks 2/4

Johnson & Johnson's CEO is Joaquin Duato, appointed in Jan 2022, has a tenure of 2.75 years. total yearly compensation is $28.40M, comprised of 5.6% salary and 94.4% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth €53.19M. The average tenure of the management team and the board of directors is 4.9 years and 4.8 years respectively.

Key information

Joaquin Duato

Chief executive officer

US$28.4m

Total compensation

CEO salary percentage5.6%
CEO tenure2.8yrs
CEO ownership0.02%
Management average tenure4.9yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joaquin Duato's remuneration changed compared to Johnson & Johnson's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

US$16b

Mar 31 2024n/an/a

US$17b

Dec 31 2023US$28mUS$2m

US$13b

Oct 01 2023n/an/a

US$12b

Jul 02 2023n/an/a

US$12b

Apr 02 2023n/an/a

US$11b

Jan 01 2023US$13mUS$1m

US$16b

Oct 02 2022n/an/a

US$18b

Jul 03 2022n/an/a

US$17b

Apr 03 2022n/an/a

US$20b

Jan 02 2022US$14mUS$1m

US$18b

Oct 03 2021n/an/a

US$18b

Jul 04 2021n/an/a

US$18b

Apr 04 2021n/an/a

US$15b

Jan 03 2021n/an/a

US$15b

Sep 27 2020n/an/a

US$17b

Jun 28 2020n/an/a

US$15b

Mar 29 2020n/an/a

US$17b

Dec 29 2019US$13mUS$970k

US$15b

Sep 29 2019n/an/a

US$14b

Jun 30 2019n/an/a

US$16b

Mar 31 2019n/an/a

US$15b

Dec 30 2018US$9mUS$934k

US$15b

Sep 30 2018n/an/a

US$2b

Jul 01 2018n/an/a

US$1b

Apr 01 2018n/an/a

US$1b

Dec 31 2017US$19mUS$897k

US$1b

Compensation vs Market: Joaquin's total compensation ($USD28.40M) is above average for companies of similar size in the Austrian market ($USD4.40M).

Compensation vs Earnings: Joaquin's compensation has increased by more than 20% in the past year.


CEO

Joaquin Duato (61 yo)

2.8yrs

Tenure

US$28,397,240

Compensation

Mr. Joaquin Duato serves as Chief Executive Officer & Director of Johnson & Johnson since January 3, 2022 and serves as its Chairman since January 02, 2023. He served as Worldwide Chairman of Pharmaceutica...


Leadership Team

NamePositionTenureCompensationOwnership
Joaquin Duato
CEO & Chairman2.8yrsUS$28.40m0.015%
$ 53.2m
Joseph Wolk
Executive VP & CFO6.3yrsUS$13.91m0.0029%
$ 10.4m
Peter Fasolo
Executive VP & Chief Human Resources Officer8.5yrsUS$7.50m0.0047%
$ 16.4m
Jennifer Taubert
Executive VP & Worldwide Chairman of Innovative Medicine12.8yrsUS$11.00m0.0064%
$ 22.6m
John Reed
Executive Vice President of Innovative Medicine1.5yrsUS$20.65m0.00048%
$ 1.7m
Robert Decker
Controller & Chief Accounting Officer4.8yrsno data0.00082%
$ 2.9m
James Swanson
Executive VP & Chief Information Officer4.9yrsno data0.00061%
$ 2.1m
Jessica Moore
Vice President of Investor Relations2.9yrsno datano data
Dirk Brinckman
Chief Compliance Officerno datano datano data
Elizabeth Forminard
Executive VP & Chief Legal Officer2yrsno data0.00035%
$ 1.2m
Guy Lebeau
Group Chairman of MD&D Business - EMEAno datano datano data
William Hait
Executive VP17.8yrsno data0.0016%
$ 5.7m

4.9yrs

Average Tenure

60yo

Average Age

Experienced Management: JNJ's management team is considered experienced (4.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Joaquin Duato
CEO & Chairman2.8yrsUS$28.40m0.015%
$ 53.2m
Anne Mulcahy
Independent Director15.8yrsUS$410.00k0.00034%
$ 1.2m
Hubert Joly
Independent Director4.8yrsUS$320.00k0.00021%
$ 738.3k
Marillyn Hewson
Lead Independent Director5.5yrsUS$360.00k0.00012%
$ 421.9k
Paula Johnson
Independent Director1.7yrsUS$352.97k0.000010%
$ 35.2k
Mark McClellan
Independent Director11yrsUS$320.00k0%
$ 0
Mary Beckerle
Independent Director9.3yrsUS$355.00k0%
$ 0
Darius Adamczyk
Independent Director2.7yrsUS$340.00k0.000040%
$ 140.6k
Jennifer Doudna
Independent Director6.5yrsUS$320.00k0%
$ 0
Eugene Woods
Independent Directorless than a yearUS$89.15kno data
Mark Weinberger
Independent Director4.8yrsUS$340.00k0%
$ 0
Nadja West
Independent Director3.8yrsUS$340.00k0%
$ 0

4.8yrs

Average Tenure

62.5yo

Average Age

Experienced Board: JNJ's board of directors are considered experienced (4.8 years average tenure).